Skip to main content

Table 10 Adverse events during the study

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 

Rash

Sore Throat, Dry Throat

Low WBC

Elevated transaminase

Cessation of menstruation (Pregnancy)

Total

Control group (n =87)

n

0

0

2

0

1

3

Severity

Moderate

Severe

 

Relation to the investigational drug

Unrelated

Unrelated

 

IFNα1b group (n =77)

n

2

1

1

1

0

5

Severity

Mild

Mild

Mild

Moderate

 

Relation to the investigational drug

Possible

Possible

Unrelated

Unrelated